Italy Diabetes Associated Ophthalmic Treatment Market Size & Outlook

The diabetes associated ophthalmic treatment market in Italy is expected to reach a projected revenue of US$ 1,516.7 million by 2028. A compound annual growth rate of 6.9% is expected of Italy diabetes associated ophthalmic treatment market from 2021 to 2028.
Revenue, 2020 (US$M)
$892.1
Forecast, 2028 (US$M)
$1,516.7
CAGR, 2021 - 2028
6.9%
Report Coverage
Italy

Italy diabetes associated ophthalmic treatment market, 2017-2028 (US$M)

Italy

Related Markets

Italy diabetes associated ophthalmic treatment market highlights

  • The Italy diabetes associated ophthalmic treatment market generated a revenue of USD 892.1 million in 2020 and is expected to reach USD 1,516.7 million by 2028.
  • The Italy market is expected to grow at a CAGR of 6.9% from 2021 to 2028.
  • In terms of segment, diabetic retinopathy was the largest revenue generating application in 2020.
  • Dry Eye Syndrome is the most lucrative application segment registering the fastest growth during the forecast period.

Diabetes associated ophthalmic treatment market data book summary

Market revenue in 2020USD 892.1 million
Market revenue in 2028USD 1,516.7 million
Growth rate6.9% (CAGR from 2020 to 2028)
Largest segmentDiabetic retinopathy
Fastest growing segmentDry Eye Syndrome
Historical data2017 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationDry Eye Syndrome, Glaucoma, Eye Allergy & Infection, Diabetic Retinopathy, Diabetic-associated Macular Degeneration, Uveitis, Cataract, Diabetic Macular Edema, Other Application
Key market players worldwideAlcon Inc, Johnson & Johnson, Bausch Health Companies Inc, Roche, Allergan, Bayer AG, Santen Pharmaceutical Co Ltd, Novartis AG ADR, Pfizer Inc, Genentech, Carl Zeiss Meditec AG, Lumenis, Ellex, IRIDEX Corp, Topcon Corp, Abbott Laboratories, Quantel

Other key industry trends

  • In terms of revenue, Italy accounted for 3.3% of the global diabetes associated ophthalmic treatment market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Europe, Germany diabetes associated ophthalmic treatment market is projected to lead the regional market in terms of revenue in 2028.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 2,744.0 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Diabetes Associated Ophthalmic Treatment Market Scope

Diabetes associated ophthalmic treatment market segmentation & scope
Dry Eye Syndrome
Glaucoma
Eye Allergy & Infection
Diabetic Retinopathy
Diabetic-associated Macular Degeneration
Uveitis
Cataract
Diabetic Macular Edema
Other Application
Drugs
Devices
Hospitals
Ophthalmic Centers
Ambulatory Centers
Others End Use

Diabetes Associated Ophthalmic Treatment Market Companies

Name Profile # Employees HQ Website

Italy diabetes associated ophthalmic treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes associated ophthalmic treatment market will help companies and investors design strategic landscapes.


Diabetic retinopathy was the largest segment with a revenue share of 26.32% in 2020. Horizon Databook has segmented the Italy diabetes associated ophthalmic treatment market based on dry eye syndrome, glaucoma, eye allergy & infection, diabetic retinopathy, diabetic-associated macular degeneration, uveitis, cataract, diabetic macular edema, other application covering the revenue growth of each sub-segment from 2017 to 2028.


  • Italy Diabetes Associated Ophthalmic Treatment Application Outlook (Revenue, USD Million, 2017-2028)
    • Dry Eye Syndrome
    • Glaucoma
    • Eye Allergy & Infection
    • Diabetic Retinopathy
    • Diabetic-associated Macular Degeneration
    • Uveitis
    • Cataract
    • Diabetic Macular Edema
    • Other Application
  • Italy Diabetes Associated Ophthalmic Treatment Type Outlook (Revenue, USD Million, 2017-2028)
    • Drugs
    • Devices
  • Italy Diabetes Associated Ophthalmic Treatment End Use Outlook (Revenue, USD Million, 2017-2028)
    • Hospitals
    • Ophthalmic Centers
    • Ambulatory Centers
    • Others End Use

Reasons to subscribe to Italy diabetes associated ophthalmic treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Italy diabetes associated ophthalmic treatment market databook

  • Our clientele includes a mix of diabetes associated ophthalmic treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Italy diabetes associated ophthalmic treatment market, including forecasts for subscribers. This country databook contains high-level insights into Italy diabetes associated ophthalmic treatment market from 2017 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Italy diabetes associated ophthalmic treatment market size, by application, 2017-2028 (US$M)

Italy Diabetes Associated Ophthalmic Treatment Market Share, 2020 & 2028 (US$M)

Italy diabetes associated ophthalmic treatment market size, by application, 2017-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more